Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03741868 · ClinicalTrials.gov registry record
Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 60
- Enrollment target
NCT03741868 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 60 participants.
The verdict
NCT03741868 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
Doctors are recruiting patients receiving care for lung cancer at the Wake Forest Baptist Comprehensive Cancer Center asking about needs and experiences during immunotherapy. Immunotherapy is a new treatment for lung cancer. The research is to better understand patients' perspectives on what immunotherapy is like and will provide important information to help understand the symptoms patients experience, the impact of treatment on daily life, ways that people adapt to the challenges of treatment, and services that may help people live better during treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-10-16 |
| Est. Completion | 2019-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03741868
The ClinicalTrials.gov registry entry for NCT03741868 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03741868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03741868 about?
NCT03741868 is a clinical study titled "Symptom Burden and Unmet Supportive Care Needs in Lung Cancer Patients Undergoing First or Second Line Immunotherapy". Doctors are recruiting patients receiving care for lung cancer at the Wake Forest Baptist Comprehensive Cancer Center asking about needs and experiences during immunotherapy. Immunotherapy is a new treatment for lung cancer. The research is to better understand patients' perspectives on what immunot...
What is the current status of trial NCT03741868?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2016-10-16. Estimated completion is 2019-02-01.
Who is sponsoring clinical trial NCT03741868?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.